- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 293/12 - SelenazolesHydrogenated selenazoles
Patent holdings for IPC class C07D 293/12
Total number of patents in this class: 42
10-year publication summary
|
2
|
2
|
3
|
2
|
7
|
4
|
5
|
2
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nanoquantum Sciences, Inc. | 6 |
4 |
| The University Court of the University of Edinburgh | 475 |
4 |
| Xwpharma Ltd. | 57 |
4 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 32 |
3 |
| Shanghai Yuanxi Medicine Corp. | 8 |
3 |
| Emory University | 1629 |
2 |
| Washington University | 1613 |
2 |
| The Regents of the University of California | 19929 |
1 |
| Canon Inc. | 39960 |
1 |
| Centre National de La Recherche Scientifique | 10432 |
1 |
| Dalian Chromas Bioscience Co., Ltd. | 10 |
1 |
| Dalian University of Technology | 1520 |
1 |
| Guangdong Aglaia Optoelectronic Materials Co., Ltd. | 166 |
1 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2833 |
1 |
| King Faisal University | 916 |
1 |
| Michigan State University | 63 |
1 |
| National Research Council of Canada | 1551 |
1 |
| Oxford University Innovation Limited | 1529 |
1 |
| Raynergy Tek Inc. | 110 |
1 |
| Santen Pharmaceutical Co., Ltd. | 596 |
1 |
| Other owners | 7 |